Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Investigational Drugs|May 9, 2002
The therapeutic potential of dopamine modulators on the cardiovascular and renal systemsSheila A Doggrell
Expert Opinion on Investigational Drugs|June 5, 2003
Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|January 9, 2003
Losartan for LIFE in hypertension with left ventricular hypertrophy?Sheila A Doggrell
Expert Opinion on Investigational Drugs|November 20, 2002
The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular systemSheila A Doggrell
Expert Opinion on Investigational Drugs|June 27, 2002
TACE inhibition: a new approach to treating inflammationSheila A Doggrell
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2003
Clinical trials with glycoprotein IIb/IIIa antagonists - No benefit without bleeding?Sheila A. Doggrell
Expert Opinion on Biological Therapy|December 9, 2020
Will evinacumab become the standard treatment for homozygous familial hypercholesterolemia?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|December 16, 2021
Adding liraglutide to diet and exercise to maintain weight loss - is it worth it?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|June 17, 2005
Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleedingSheila A Doggrell
Expert Opinion on Pharmacotherapy|September 8, 2005
Ximelagatran--recent comparisons with warfarinSheila A Doggrell
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Investigational Drugs|May 9, 2002
The therapeutic potential of dopamine modulators on the cardiovascular and renal systemsSheila A Doggrell
Expert Opinion on Investigational Drugs|June 5, 2003
Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|January 9, 2003
Losartan for LIFE in hypertension with left ventricular hypertrophy?Sheila A Doggrell
Expert Opinion on Investigational Drugs|November 20, 2002
The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular systemSheila A Doggrell
Expert Opinion on Investigational Drugs|June 27, 2002
TACE inhibition: a new approach to treating inflammationSheila A Doggrell
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2003
Clinical trials with glycoprotein IIb/IIIa antagonists - No benefit without bleeding?Sheila A. Doggrell
Expert Opinion on Biological Therapy|December 9, 2020
Will evinacumab become the standard treatment for homozygous familial hypercholesterolemia?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|December 16, 2021
Adding liraglutide to diet and exercise to maintain weight loss - is it worth it?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|June 17, 2005
Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleedingSheila A Doggrell
Expert Opinion on Pharmacotherapy|September 8, 2005
Ximelagatran--recent comparisons with warfarinSheila A Doggrell
Pageof 22